Why the study?
Fixed-dose regimens of 4F-PCC may effectively reverse warfarin emergently, but optimal dosing remains unknown.
Does a fixed-dose regimen of 4F-PCC achieve target INR comparably to weight-based dosing in patients requiring emergent warfarin reversal?
Does a fixed-dose regimen of 4F-PCC achieve target INR comparably to weight-based dosing in patients requiring emergent warfarin reversal?
A fixed-dose strategy of 2000 units of 4F-PCC for warfarin reversal is comparable to weight-based dosing for CNS bleeds or INR ≥6.1, but a 1000-unit dose for INR ≤6 is less effective at achieving target INR.
Answers are grounded in this paper and cite their sources.
Fixed-dose 4F-PCC may underperform weight-based dosing for INR ≤6 non-CNS bleeds; leaves open optimal regimens pending randomized confirmation.
Background: Fixed-dose (FD) regimens of 4-factor prothrombin complex concentrate (4F-PCC) may be effective for the emergent reversal of warfarin; however, the optimal dosing is unknown. Our institution transitioned to a FD regimen of 1000 or 2000 units of 4F-PCC based on indication. Objective: The purpose of this study is to report our experience with FD 4F-PCC compared with a historical weight-based dosing cohort for warfarin reversal. Methods: A retrospective analysis was conducted for 3 groups: central nervous system (CNS) bleeds regardless of international normalized ratio (INR), non-CNS bleeds with an initial INR ≤6, and non-CNS bleeds with an initial INR ≥6.1. The primary outcome of the study was achievement of the target INR. Results: There were 54 patients with a CNS bleed, 153 with a non-CNS bleed and INR ≤6, and 19 with a non-CNS bleed and INR ≥6.1. In the CNS bleeding group, weight-based and FD achieved target INR 79.4% and 70% ( P = 0.52). In the INR ≥6.1 non-CNS bleeding group, weight-based and FD achieved target INR 100% and 70% ( P = 0.21). In the INR ≤6 non-CNS bleeding group, weight-based and FD achieved target INR 86.4% and 57.5% ( P = 0.0002). Conclusion and Relevance: An FD strategy of 2000 units for warfarin reversal for CNS bleeds or INR ≥6.1 was comparable to weight-based dosing. The FD strategy of 1000 units for INR ≤6 achieved target INR less often than weight-based dosing. Application of findings suggest that higher doses may be needed to achieve target INR.
No takes yet. Share an insight, caveat, or question.
McMahon et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: